Literature DB >> 32362129

Impact of mail order pharmacy use and travel time to pharmacy on viral suppression among people living with HIV.

Jessica P Ridgway1,2, Eleanor E Friedman2, Justine Choe3, Cynthia T Nguyen3, Todd Schuble4, Natasha N Pettit3.   

Abstract

This study aimed to evaluate the impact of mail order pharmacy services and travel time to pharmacy on HIV viral suppression rates among people living with HIV. For adult patients receiving HIV care from 2010 to 2015 at an urban HIV care clinic, we collected demographics, pharmacy type, viral load, and patient home and pharmacy address. We geocoded addresses and measured travel time to pharmacy by car and public transportation. No difference was observed in recent viral suppression rates based on pharmacy type (p = 0.41), distance to pharmacy (p = 0.16), or travel time to pharmacy by car (p = 0.20) or public transportation (p = 0.15). The only factors significantly associated with sustained viral suppression were number of doses per day of antiretroviral therapy, with patients prescribed twice daily regimens less likely to be virally suppressed than those prescribed once daily regimens (aOR 0.4, 95% CI, [0.1, 0.6]) and average household income in patients' zip code, with patients living in zip codes with average household income <$40,000 per year less likely to be virally suppressed than those living in zip codes with average income >$55,000 per year (aOR 0.2. 95% CI, [0.1, 0.7]).

Entities:  

Keywords:  HIV; adherence; antiretroviral therapy; pharmacy

Mesh:

Substances:

Year:  2020        PMID: 32362129      PMCID: PMC7572477          DOI: 10.1080/09540121.2020.1757019

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  18 in total

1.  U=U taking off in 2017.

Authors: 
Journal:  Lancet HIV       Date:  2017-11       Impact factor: 12.767

2.  Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy.

Authors:  Baligh R Yehia; John A Fleishman; Joshua P Metlay; Richard D Moore; Kelly A Gebo
Journal:  JAMA       Date:  2012-07-25       Impact factor: 56.272

3.  Forget about forgetting: structural barriers and severe non-adherence to antiretroviral therapy.

Authors:  Seth C Kalichman; Moira O Kalichman; Chauncey Cherry
Journal:  AIDS Care       Date:  2016-08-18

4.  Individual and community factors associated with geographic clusters of poor HIV care retention and poor viral suppression.

Authors:  Michael G Eberhart; Baligh R Yehia; Amy Hillier; Chelsea D Voytek; Danielle J Fiore; Michael Blank; Ian Frank; David S Metzger; Kathleen A Brady
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

5.  Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.

Authors:  Joel E Gallant; Edwin DeJesus; José R Arribas; Anton L Pozniak; Brian Gazzard; Rafael E Campo; Biao Lu; Damian McColl; Steven Chuck; Jeffrey Enejosa; John J Toole; Andrew K Cheng
Journal:  N Engl J Med       Date:  2006-01-19       Impact factor: 91.245

6.  HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015: A Cohort Study.

Authors:  Robin M Nance; J A Chris Delaney; Jane M Simoni; Ira B Wilson; Kenneth H Mayer; Bridget M Whitney; Frances M Aunon; Steven A Safren; Michael J Mugavero; W Christopher Mathews; Katerina A Christopoulos; Joseph J Eron; Sonia Napravnik; Richard D Moore; Benigno Rodriguez; Bryan Lau; Rob J Fredericksen; Michael S Saag; Mari M Kitahata; Heidi M Crane
Journal:  Ann Intern Med       Date:  2018-08-21       Impact factor: 25.391

7.  Understanding Local Spatial Variation Along the Care Continuum: The Potential Impact of Transportation Vulnerability on HIV Linkage to Care and Viral Suppression in High-Poverty Areas, Atlanta, Georgia.

Authors:  Neela D Goswami; Michelle M Schmitz; Travis Sanchez; Sharoda Dasgupta; Patrick Sullivan; Hannah Cooper; Deepali Rane; Jane Kelly; Carlos Del Rio; Lance A Waller
Journal:  J Acquir Immune Defic Syndr       Date:  2016-05-01       Impact factor: 3.731

8.  Determination of the influence of home delivery of HIV therapy on virological outcomes and adherence.

Authors:  Sheena Castelino; Hamida Miah; Vivian Auyeung; Florian Vogt
Journal:  Int J STD AIDS       Date:  2014-04-14       Impact factor: 1.359

9.  Mortality and progression to AIDS after starting highly active antiretroviral therapy.

Authors:  Ard I van Sighem; Mark A van de Wiel; Azra C Ghani; Mariëlle Jambroes; Peter Reiss; Inge C Gyssens; Kees Brinkman; Joep M A Lange; Frank de Wolf
Journal:  AIDS       Date:  2003-10-17       Impact factor: 4.177

Review 10.  Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis.

Authors:  Zara Shubber; Edward J Mills; Jean B Nachega; Rachel Vreeman; Marcelo Freitas; Peter Bock; Sabin Nsanzimana; Martina Penazzato; Tsitsi Appolo; Meg Doherty; Nathan Ford
Journal:  PLoS Med       Date:  2016-11-29       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.